Gilead reports positive data in trial of possible virus drug

Gilead Sciences said Wednesday it is aware of “positive data” from one of its studies looking at antiviral drug remdesivir as a potential treatment for the coronavirus. Shares of Gilead were halted in premarket trading. This is breaking news. Please check back for updates.